Search Results - M. Ulrickson

444 | A PHASE 1 STUDY OF SGR‐1505, AN ORAL, POTENT MALT1 INHIBITOR FOR R/R B‐CELL MALIGNANCIES, INCLUDING CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL) Autoría: V. Musteata, S. Spurgeon, O. Karnabeda, M. Di, N. Gabrail, G. S. Guru Murthy, W. Yin, A. Upalawanna, S. Zhang, V. Gupta, B. Yoo, F. G. Basile, M. Dugan, M. Ulrickson, A. Olszewski